AAAAAA

   
Results: 1-25 | 26-47 |
Results: 26-47/47
Gene therapy for cardiovascular disease and vascular grafts
Authors: Ehsan, A Mann, MJ Dzau, VJ
Citation: A. Ehsan et al., Gene therapy for cardiovascular disease and vascular grafts, GENE THERAPY, 2000, pp. 421-438
Revolution and renaissance
Authors: Dzau, VJ Austin, MJF Brown, P Cowley, A Housman, D Mulligan, R Rosenberg, R
Citation: Vj. Dzau et al., Revolution and renaissance, PHYSIOL GEN, 1(1), 1999, pp. 1-2
A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer
Authors: von der Leyen, HE Braun-Dullaeus, R Mann, MJ Zhang, LN Niebauer, J Dzau, VJ
Citation: He. Von Der Leyen et al., A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer, HUM GENE TH, 10(14), 1999, pp. 2355-2364
The renin-angiotensin-aldosterone system: A specific target for hypertension management
Authors: Weir, MR Dzau, VJ
Citation: Mr. Weir et Vj. Dzau, The renin-angiotensin-aldosterone system: A specific target for hypertension management, AM J HYPERT, 12(12), 1999, pp. 205S-213S
Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis
Authors: Lehtonen, JYA Daviet, L Nahmias, C Horiuchi, M Dzau, VJ
Citation: Jya. Lehtonen et al., Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis, MOL ENDOCR, 13(7), 1999, pp. 1051-1060
AT(2) receptor and vascular smooth muscle cell differentiation in vasculardevelopment
Authors: Yamada, H Akishita, M Ito, M Tamura, K Daviet, L Lehtonen, JYA Dzau, VJ Horiuchi, M
Citation: H. Yamada et al., AT(2) receptor and vascular smooth muscle cell differentiation in vasculardevelopment, HYPERTENSIO, 33(6), 1999, pp. 1414-1419
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
Authors: Horiuchi, M Akishita, M Dzau, VJ
Citation: M. Horiuchi et al., Recent progress in angiotensin II type 2 receptor research in the cardiovascular system, HYPERTENSIO, 33(2), 1999, pp. 613-621
Genomics and hypertension - Concepts, potentials, and opportunities
Authors: Pratt, RE Dzau, VJ
Citation: Re. Pratt et Vj. Dzau, Genomics and hypertension - Concepts, potentials, and opportunities, HYPERTENSIO, 33(1), 1999, pp. 238-247
Interferon regulatory factors regulate interleukin-1 beta-converting enzyme expression and apoptosis in vascular smooth muscle cells
Authors: Horiuchi, M Yamada, H Akishita, M Ito, M Tamura, K Dzau, VJ
Citation: M. Horiuchi et al., Interferon regulatory factors regulate interleukin-1 beta-converting enzyme expression and apoptosis in vascular smooth muscle cells, HYPERTENSIO, 33(1), 1999, pp. 162-166
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial
Authors: Mann, MJ Whittemore, AD Donaldson, MC Belkin, M Conte, MS Polak, JF Orav, EJ Ehsan, A Dell'Acqua, G Dzau, VJ
Citation: Mj. Mann et al., Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial, LANCET, 354(9189), 1999, pp. 1493-1498
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method
Authors: Poston, RS Mann, MJ Hoyt, EG Ennen, M Dzau, VJ Robbins, RC
Citation: Rs. Poston et al., Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method, TRANSPLANT, 68(6), 1999, pp. 825-832
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues
Authors: Mann, MJ Gibbons, GH Hutchinson, H Poston, RS Hoyt, EG Robbins, RC Dzau, VJ
Citation: Mj. Mann et al., Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues, P NAS US, 96(11), 1999, pp. 6411-6416
A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy
Authors: Braun-Dullaeus, RC Mann, MJ Ziegler, A von der Leyen, HE Dzau, VJ
Citation: Rc. Braun-dullaeus et al., A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy, J CLIN INV, 104(6), 1999, pp. 815-823
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
Authors: Akishita, M Ito, M Lehtonen, YA Daviet, L Dzau, VJ Horiuchi, M
Citation: M. Akishita et al., Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth, J CLIN INV, 103(1), 1999, pp. 63-71
Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis
Authors: Lehtonen, JYA Horiuchi, M Daviet, L Akishita, M Dzau, VJ
Citation: Jya. Lehtonen et al., Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis, J BIOL CHEM, 274(24), 1999, pp. 16901-16906
Cloning and characterization of ATRAP, a novel protein that interacts withthe angiotensin II type 1 receptor
Authors: Daviet, L Lehtonen, JYA Tamura, K Griese, DP Horiuchi, M Dzau, VJ
Citation: L. Daviet et al., Cloning and characterization of ATRAP, a novel protein that interacts withthe angiotensin II type 1 receptor, J BIOL CHEM, 274(24), 1999, pp. 17058-17062
Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo
Authors: Tomita, S Tomita, N Yamada, T Zhang, LN Kaneda, Y Morishita, R Ogihara, T Dzau, VJ Horiuchi, M
Citation: S. Tomita et al., Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo, CIRCUL RES, 84(9), 1999, pp. 1059-1066
Stimulation of different subtypes of angiotensin II receptors, AT(1) and AT(2) receptors, regulates STAT activation by negative crosstalk
Authors: Horiuchi, M Hayashida, W Akishita, M Tamura, K Daviet, L Lehtonen, JYA Dzau, VJ
Citation: M. Horiuchi et al., Stimulation of different subtypes of angiotensin II receptors, AT(1) and AT(2) receptors, regulates STAT activation by negative crosstalk, CIRCUL RES, 84(8), 1999, pp. 876-882
Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x
Authors: Ing, DJ Zang, J Dzau, VJ Webster, KA Bishopric, NH
Citation: Dj. Ing et al., Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x, CIRCUL RES, 84(1), 1999, pp. 21-33
Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor
Authors: Akishita, M Yamada, H Dzau, VJ Horiuchi, M
Citation: M. Akishita et al., Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor, BIOC BIOP R, 261(2), 1999, pp. 345-349
Assessing the value of hospitalists to academic health centers: Brigham and Women's Hospital and Harvard Medical School
Authors: Brown, MD Halpert, A McKean, S Sussman, A Dzau, VJ
Citation: Md. Brown et al., Assessing the value of hospitalists to academic health centers: Brigham and Women's Hospital and Harvard Medical School, AM J MED, 106(2), 1999, pp. 134-137
Molecular and cellular mechanism of angiotensin II-mediated apoptosis
Authors: Horiuchi, M Akishita, M Dzau, VJ
Citation: M. Horiuchi et al., Molecular and cellular mechanism of angiotensin II-mediated apoptosis, ENDOCRINE R, 24(3-4), 1998, pp. 307-314
Risultati: 1-25 | 26-47 |